DOCSLIB.ORG

TCR Signal Strength Regulates Akt Substrate Specificity to Induce

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
TCR Signal Strength Regulates Akt Substrate Specificity to Induce TCR Signal Strength Regulates Akt Substrate Specificity To Induce Alternate Murine Th and T Regulatory Cell Differentiation Programs This information is current as of September 27, 2021. William F. Hawse, William C. Boggess and Penelope A. Morel J Immunol published online 9 June 2017 http://www.jimmunol.org/content/early/2017/06/09/jimmun ol.1700369 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2017/06/09/jimmunol.170036 Material 9.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published June 9, 2017, doi:10.4049/jimmunol.1700369 The Journal of Immunology TCR Signal Strength Regulates Akt Substrate Specificity To Induce Alternate Murine Th and T Regulatory Cell Differentiation Programs William F. Hawse,* William C. Boggess,† and Penelope A. Morel* The Akt/mTOR pathway is a key driver of murine CD4+ T cell differentiation, and induction of regulatory T (Treg) cells results from low TCR signal strength and low Akt/mTOR signaling. However, strong TCR signals induce high Akt activity that promotes Th cell induction. Yet, it is unclear how Akt controls alternate T cell fate decisions. We find that the strength of the TCR signal results in differential Akt enzymatic activity. Surprisingly, the Akt substrate networks associated with T cell fate decisions are qualitatively different. Proteomic profiling of Akt signaling networks during Treg versus Th induction demonstrates that Akt differentially regulates RNA processing and splicing factors to drive T cell differentiation. Interestingly, heterogeneous nuclear Downloaded from ribonucleoprotein (hnRNP) L or hnRNP A1 are Akt substrates during Treg induction and have known roles in regulating the stability and splicing of key mRNAs that code for proteins in the canonical TCR signaling pathway, including CD3z and CD45. Functionally, inhibition of Akt enzymatic activity results in the dysregulation of splicing during T cell differentiation, and knockdown of hnRNP L or hnRNP A1 results in the lower induction of Treg cells. Together, this work suggests that a switch in substrate specificity coupled to the phosphorylation status of Akt may lead to alternative cell fates and demonstrates that proteins involved with alternative splicing are important factors in T cell fate decisions. The Journal of Immunology, 2017, 199: 000–000. http://www.jimmunol.org/ D4+ regulatory T (Treg) cells prevent autoimmunity and regulate other key proteins important for the differentiation control immunopathology during immune responses. and function of either Th or Treg cells. There are .100 known C The TCR binds to peptide–MHC complexes, initiating a Akt substrates (11), yet the full network of substrates phosphor- signaling cascade that determines the fate of the T cell. The ylated by Akt during Th or Treg differentiation remains largely Akt/mTOR pathway plays a critical role in determining CD4+ unexplored. T cell fate (1–3). The induction of Treg cells is inversely correlated To better define how Akt functions in T cell differentiation, we with the degree of Akt/mTOR signaling (1–3). A low degree of identified Akt substrates during the induction of Th and Treg cells Akt/mTOR signaling is necessary for Treg stability and function via mass spectrometry. Remarkably, phosphorylated Akt substrates by guest on September 27, 2021 (4–6). Akt/mTOR signaling is tightly regulated in T cells, and differed during Treg versus Th cell induction, and this was asso- several feedback loops control the degree of Akt/mTOR activation, ciated with different patterns of Akt phosphorylation under both one of which involves phosphatase and tensin homolog (PTEN), the conditions. RNA processing factors were major Akt targets during transcription factors Foxp3 and FoxO1, and mTORC2 (7, 8). both Th and Treg induction, including heterogeneous nuclear ri- Akt is a serine threonine kinase that regulates cellular processes bonucleoprotein (hnRNP) L and hnRNP A1. We determined that including cell proliferation and cellular metabolism (9, 10). Akt RNA splicing of TCR signaling proteins, such as CD3z and CD45, activity is controlled by phosphorylation at Ser473 and Thr308. was regulated by Akt and essential for the Th versus Treg cell fate When Treg cells are activated, only Akt Thr308 is phosphorylated, choice. Knockdown of hnRNP L or hnRNP A1 altered the TCR and phosphorylation of both Thr308 and Ser473 sites results in the signal and changed the ratios of Th versus Treg cells induced. loss of Treg suppressive function (4). It appears that Treg function Together, these results reveal that there are distinct Akt signaling depends on the ability to modulate Akt activity and that Akt may networks that drive Th versus Treg induction, and identify RNA splicing factors as determinants of CD4+ T cell fate decisions. *Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261; and †Department of Chemistry and Biochemistry, University of Notre Dame, Notre Materials and Methods Dame, IN 46556 Mice ORCIDs: 0000-0001-8371-3345 (W.F.H.); 0000-0002-1743-3676 (P.A.M.). C57BL/6 mice were purchased from The Jackson Laboratory. C57BL/6- Received for publication March 13, 2017. Accepted for publication May 19, 2017. Foxp3tm1Flv/J (Foxp3-RFP reporter) mice were a kind gift from Dr. D. This work was supported by National Institutes of Health Training Grant T32 Vignali (University of Pittsburgh). All of the mice were housed in a AI089443 (to W.F.H.) and by a Competitive Medical Research Fund grant from pathogen-free facility at the University of Pittsburgh. Mice were handled the University of Pittsburgh Medical Center (to W.F.H.). under Institutional Animal Care and Use Committee–approved guidelines in accordance with approved protocols. Address correspondence and reprint requests to Dr. Penelope A. Morel, University of Pittsburgh, 200 Lothrop Street, BST E1055, Pittsburgh, PA 15261. E-mail address: CD4+ T cell isolation and activation [email protected] + The online version of this article contains supplemental material. CD4 T cells were isolated as previously described (7). For the mass spectrometry and biochemical experiments, CD4+ T cells were isolated Abbreviations used in this article: hnRNP, heterogeneous nuclear ribonucleoprotein; + iAkt, Akt inhibitor; IP, immunoprecipitate; nTreg, natural Treg; PTEN, phosphatase from C57BL/6 spleens using a CD4 negative selection kit (Miltenyi and tensin homolog; QE, Q-Exactive; qPCR, quantitative PCR; siRNA, small interfering Biotec). Induction of Treg and Th cells was performed as previously de- + RNA; Treg, regulatory T. scribed (7). To generate Treg cells, we activated freshly isolated CD4 T cells with 0.25 mg/ml plate-bound anti-CD3 mAb with 1 mg/ml soluble Copyright Ó 2017 by The American Association of Immunologists, Inc. 0022-1767/17/$30.00 anti-CD28 mAb. To generate Th cells, we activated freshly isolated CD4+ www.jimmunol.org/cgi/doi/10.4049/jimmunol.1700369 2 TCR SIGNAL STRENGTH DETERMINES Akt SUBSTRATE SPECIFICITY T cells with 1.0 mg/ml plate-bound anti-CD3 mAb with 1 mg/ml soluble CD45 splicing assay + anti-CD28 mAb. In some experiments, natural Treg (nTreg; CD4 Foxp3- + RFP+) and naive T (CD4+ Foxp3-RFP2) cells were sorted using a FAC- Total RNA was isolated from CD4 T cells with the RNeasy Plus Mini Kit SAria from the spleen of Foxp3-RFP reporter mice. (Qiagen). Reverse transcription reactions were performed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). A CD45 Immunoprecipitation of Akt substrates and generation of Akt splicing assay was performed as previously described (14). In brief, prim- 9 substrate tryptic fragments ers were designed to flank exons 4–6 of CD45 (primer 1: 5 -GGCAA- CACCTACACCCA-39, primer 2: 59-GCTTGCAGGCCCAGA-39). PCRs Five million CD4+ T cells were activated in Treg or Th conditions in the (30 cycles) were performed using the goTaq DNA polymerase (Promega). presence or absence of an Akt inhibitor (iAkt; Akt1/2 10 mM). After PCRs were resolved on a 1% agarose gel, SeaKem LE Agarose (Lonza), 15 min of activation, cells were lysed in 500 ml of ice-cold buffer con- stained with ethidium bromide (Sigma) and imaged on a Red imaging taining 0.5% (v/v) Nonidet P-40, 1% (v/v) Triton X-100, 150 mM NaCl, system (Protein system). 50 mM Tris-HCl [pH 7.4], 1 mM EDTA, and 1 mM EGTA. The lysis buffer also contained protease and phosphatase inhibitors (1 mM Na3VO4, Splice variant isoform quantitative PCR assays 1 mM aprotinin, 1 mM leupeptin, 1 mM pepstatin, 10 mM NaF, 1 mM PMSF, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate). The Total RNA was isolated and reverse transcribed as described above. Primer pairs were designed to look at the splice variant usage for Lck, Fyn Tec, and lysate was sonicated, centrifuged, and incubated with an Ab specific to + phosphorylated Akt substrate motif RXRXX (phospho-Thr/phospho-Ser) CD247 in resting and activated CD4 T cells (Table I). Quantitative PCR (Cell Signaling Technologies) at a ratio of 1 mlofAbto50ml of cell lysate (qPCR) was performed on a StepOne Plus real-time PCR system with the at 4˚C for 12 h. The Ab–Akt substrate complexes were captured by protein SYBR Green Master Mix (Applied Biosystems) from three independent + experiments.
Load more

Recommended publications
  • CD81 Antibody (C-Term) Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP6631B
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 CD81 Antibody (C-term) Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP6631B Specification CD81 Antibody (C-term) - Product Information Application WB, IHC-P, FC,E Primary Accession P60033 Reactivity Human, Mouse Host Rabbit Clonality Polyclonal Isotype Rabbit Ig Antigen Region 176-203 CD81 Antibody (C-term) - Additional Information Gene ID 975 Other Names CD81 antigen, 26 kDa cell surface protein TAPA-1, Target of the antiproliferative antibody 1, Tetraspanin-28, Tspan-28, Western blot analysis of CD81 Antibody CD81, CD81, TAPA1, TSPAN28 (C-term) (Cat. #AP6631b) in mouse kidney(lane 1) and cerebellum(lane 2) tissue Target/Specificity lysates (35ug/lane). CD81 (arrow) was This CD81 antibody is generated from detected using the purified Pab. rabbits immunized with a KLH conjugated synthetic peptide between 176-203 amino acids from the C-terminal region of human CD81. Dilution WB~~1:1000 IHC-P~~1:10~50 FC~~1:10~50 Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. Storage Maintain refrigerated at 2-8°C for up to 2 Formalin-fixed and paraffin-embedded weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw human brain tissue with CD81 Antibody cycles. (C-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB Precautions staining. This data demonstrates the use of CD81 Antibody (C-term) is for research use this antibody for immunohistochemistry; Page 1/4 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 only and not for use in diagnostic or clinical relevance has not been evaluated.
    [Show full text]
  • Review Tec Kinases: a Family with Multiple Roles in Immunity
    Immunity, Vol. 12, 373±382, April, 2000, Copyright 2000 by Cell Press Tec Kinases: A Family Review with Multiple Roles in Immunity Wen-Chin Yang,*³§ Yves Collette,*³ inositol phosphates, but they are thought to be relevant Jacques A. NuneÁ s,*³ and Daniel Olive*² for binding of PtdIns lipids to the same sites. In most *INSERM U119 cases, PH domains bind preferentially to PtdIns (4,5)P2 Universite de la Me diterrane e and inositol (1,4,5) P3 (Ins (1,4,5) P3). However, the Btk 13009 Marseille PH domain binds PtdIns (3,4,5)P3 and Ins (1, 3, 4, 5)P4 France the tightest. PtdIns (3, 4, 5)P3, one of the products of the action of PI3K, is thought to act as a second messen- ger to recruit regulatory proteins to the plasma mem- brane via their PH domains (see below). Many of the Antigen receptors on T, B, and mast cells are multimo- mutations in Btk that lead to XLA are point mutations lecular complexes that are activated by interactions with that cluster at one end of the PH domain and could be external signals. These signals are then transmitted to predicted to impair binding to Ins (3,4,5)P (for review regulate gene expression and posttranscriptional modi- 3 see Satterthwaite et al., 1998a) (Figure 1b). Similarly, fications. Nonreceptor tyrosine kinases (NRTK) are key CBA/N xid mice carry an R28C mutation in the Btk PH players that relay and integrate these signals. NRTK are domain. The recent structure of the PH domain from divided into distinct families defined by a prototypic Btk complexed with Ins (1,3,4,5)P4 provides an explana- member: Src, Tec, Syk, Csk, Fes, Abl, Jak, Fak, Ack, tion for several mutations associated with XLA: mis- Brk, and Srm (Bolen and Brugge, 1997).
    [Show full text]
  • Evidence for an Interaction Between the Insulin Receptor and Grb7. a Role for Two of Its Binding Domains, PIR and SH2
    Oncogene (2000) 19, 2052 ± 2059 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc Evidence for an interaction between the insulin receptor and Grb7. A role for two of its binding domains, PIR and SH2 Anne Kasus-Jacobi1,2,3,Ve ronique Be re ziat1,3, Dominique Perdereau1, Jean Girard1 and Anne-FrancËoise Burnol*,1 1Endocrinologie MeÂtabolisme et DeÂveloppement, CNRS, UPR 1524, 9 rue Jules Hetzel, 92190 Meudon, France The molecular adapter Grb7 is likely to be implicated in new family of adapters has recently emerged, the Grb7 the development of certain cancer types. In this study we family of proteins, comprising Grb7, Grb10 and show that Grb7 binds the insulin receptors, when they Grb14. The members of this family were originally are activated and tyrosine phosphorylated. This interac- cloned by interaction with EGF receptor, using the tion is documented by two-hybrid experiments, GST CORT (cloning of receptor target) system (Daly et al., pull-down assays and in vivo coimmunoprecipitations. In 1996; Margolis, 1994; Ooi et al., 1995), and the use of addition, our results argue in favor of a preferential the yeast two-hybrid technology has emphasized their association between Grb7 and the insulin receptors when implication in signal transduction (Daly, 1998). These compared to other tyrosine kinase receptors like the adapters bind also other tyrosine kinase receptors, like EGF receptor, the FGF receptor and Ret. Interestingly, erbB2, Ret, Elk, PDGF receptors, insulin receptors and Grb7 is not a substrate of the insulin receptor tyrosine IGF-1 receptors (Daly et al., 1996; Dey et al., 1996; kinase activity.
    [Show full text]
  • CD226 T Cells Expressing the Receptors TIGIT and Divergent Phenotypes of Human Regulatory
    The Journal of Immunology Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226 Christopher A. Fuhrman,*,1 Wen-I Yeh,*,1 Howard R. Seay,* Priya Saikumar Lakshmi,* Gaurav Chopra,† Lin Zhang,* Daniel J. Perry,* Stephanie A. McClymont,† Mahesh Yadav,† Maria-Cecilia Lopez,‡ Henry V. Baker,‡ Ying Zhang,x Yizheng Li,{ Maryann Whitley,{ David von Schack,x Mark A. Atkinson,* Jeffrey A. Bluestone,‡ and Todd M. Brusko* Regulatory T cells (Tregs) play a central role in counteracting inflammation and autoimmunity. A more complete understanding of cellular heterogeneity and the potential for lineage plasticity in human Treg subsets may identify markers of disease pathogenesis and facilitate the development of optimized cellular therapeutics. To better elucidate human Treg subsets, we conducted direct transcriptional profiling of CD4+FOXP3+Helios+ thymic-derived Tregs and CD4+FOXP3+Helios2 T cells, followed by comparison with CD4+FOXP32Helios2 T conventional cells. These analyses revealed that the coinhibitory receptor T cell Ig and ITIM domain (TIGIT) was highly expressed on thymic-derived Tregs. TIGIT and the costimulatory factor CD226 bind the common ligand CD155. Thus, we analyzed the cellular distribution and suppressive activity of isolated subsets of CD4+CD25+CD127lo/2 T cells expressing CD226 and/or TIGIT. We observed TIGIT is highly expressed and upregulated on Tregs after activation and in vitro expansion, and is associated with lineage stability and suppressive capacity. Conversely, the CD226+TIGIT2 population was associated with reduced Treg purity and suppressive capacity after expansion, along with a marked increase in IL-10 and effector cytokine production. These studies provide additional markers to delineate functionally distinct Treg subsets that may help direct cellular therapies and provide important phenotypic markers for assessing the role of Tregs in health and disease.
    [Show full text]
  • Lipid-Targeting Pleckstrin Homology Domain Turns Its Autoinhibitory Face Toward the TEC Kinases
    Lipid-targeting pleckstrin homology domain turns its autoinhibitory face toward the TEC kinases Neha Amatyaa, Thomas E. Walesb, Annie Kwonc, Wayland Yeungc, Raji E. Josepha, D. Bruce Fultona, Natarajan Kannanc, John R. Engenb, and Amy H. Andreottia,1 aRoy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA 50011; bDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115; and cInstitute of Bioinformatics and Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602 Edited by Natalie G. Ahn, University of Colorado Boulder, Boulder, CO, and approved September 17, 2019 (received for review May 3, 2019) The pleckstrin homology (PH) domain is well known for its phos- activation loop phosphorylation site are also controlled by noncatalytic pholipid targeting function. The PH-TEC homology (PHTH) domain domains (17). In addition to the N-terminal PHTH domain, the within the TEC family of tyrosine kinases is also a crucial component TEC kinases contain a proline-rich region (PRR) and Src ho- of the autoinhibitory apparatus. The autoinhibitory surface on the mology 3 (SH3) and Src homology 2 (SH2) domains that impinge PHTH domain has been previously defined, and biochemical investi- on the kinase domain to alter the conformational ensemble and gations have shown that PHTH-mediated inhibition is mutually thus the activation status of the enzyme. A crystal structure of the exclusive with phosphatidylinositol binding. Here we use hydrogen/ BTK SH3-SH2-kinase fragment has been solved (10) showing that deuterium exchange mass spectrometry, nuclear magnetic resonance the SH3 and SH2 domains of BTK assemble onto the distal side of (NMR), and evolutionary sequence comparisons to map where and the kinase domain (the surface opposite the activation loop), how the PHTH domain affects the Bruton’s tyrosine kinase (BTK) stabilizing the autoinhibited form of the kinase in a manner similar domain.
    [Show full text]
  • CD Markers Are Routinely Used for the Immunophenotyping of Cells
    ptglab.com 1 CD MARKER ANTIBODIES www.ptglab.com Introduction The cluster of differentiation (abbreviated as CD) is a protocol used for the identification and investigation of cell surface molecules. So-called CD markers are routinely used for the immunophenotyping of cells. Despite this use, they are not limited to roles in the immune system and perform a variety of roles in cell differentiation, adhesion, migration, blood clotting, gamete fertilization, amino acid transport and apoptosis, among many others. As such, Proteintech’s mini catalog featuring its antibodies targeting CD markers is applicable to a wide range of research disciplines. PRODUCT FOCUS PECAM1 Platelet endothelial cell adhesion of blood vessels – making up a large portion molecule-1 (PECAM1), also known as cluster of its intracellular junctions. PECAM-1 is also CD Number of differentiation 31 (CD31), is a member of present on the surface of hematopoietic the immunoglobulin gene superfamily of cell cells and immune cells including platelets, CD31 adhesion molecules. It is highly expressed monocytes, neutrophils, natural killer cells, on the surface of the endothelium – the thin megakaryocytes and some types of T-cell. Catalog Number layer of endothelial cells lining the interior 11256-1-AP Type Rabbit Polyclonal Applications ELISA, FC, IF, IHC, IP, WB 16 Publications Immunohistochemical of paraffin-embedded Figure 1: Immunofluorescence staining human hepatocirrhosis using PECAM1, CD31 of PECAM1 (11256-1-AP), Alexa 488 goat antibody (11265-1-AP) at a dilution of 1:50 anti-rabbit (green), and smooth muscle KD/KO Validated (40x objective). alpha-actin (red), courtesy of Nicola Smart. PECAM1: Customer Testimonial Nicola Smart, a cardiovascular researcher “As you can see [the immunostaining] is and a group leader at the University of extremely clean and specific [and] displays Oxford, has said of the PECAM1 antibody strong intercellular junction expression, (11265-1-AP) that it “worked beautifully as expected for a cell adhesion molecule.” on every occasion I’ve tried it.” Proteintech thanks Dr.
    [Show full text]
  • Insulin Receptor Membrane Retention by a Traceable Chimeric Mutant Jimena Giudice1,2,4, Elizabeth a Jares-Erijman2ˆ and Federico Coluccio Leskow1,3*
    Giudice et al. Cell Communication and Signaling 2013, 11:45 http://www.biosignaling.com/content/11/1/45 RESEARCH Open Access Insulin receptor membrane retention by a traceable chimeric mutant Jimena Giudice1,2,4, Elizabeth A Jares-Erijman2ˆ and Federico Coluccio Leskow1,3* Abstract Background: The insulin receptor (IR) regulates glucose homeostasis, cell growth and differentiation. It has been hypothesized that the specific signaling characteristics of IR are in part determined by ligand-receptor complexes localization. Downstream signaling could be triggered from the plasma membrane or from endosomes. Regulation of activated receptor's internalization has been proposed as the mechanism responsible for the differential isoform and ligand-specific signaling. Results: We generated a traceable IR chimera that allows the labeling of the receptor at the cell surface. This mutant binds insulin but fails to get activated and internalized. However, the mutant heterodimerizes with wild type IR inhibiting its auto-phosphorylation and blocking its internalization. IR membrane retention attenuates AP-1 transcriptional activation favoring Akt activation. Conclusions: These results suggest that the mutant acts as a selective dominant negative blocking IR internalization-mediated signaling. Keywords: Insulin receptor, Membrane retention, Dominant negative, Endocytosis Background events between the two isoforms, indicating specific Insulin receptor (IR) is a tetrameric tyrosine kinase re- functions [13-15]. Using an elegant harmonic oscillator ceptor involved on glucose homeostasis, cell growth and mathematical model, Knudson et al. reported that insu- differentiation. Two IR variants are produced in mam- lin has 1.5-fold higher affinity and a 2-fold higher dis- mals by alternative splicing: IR-A lacking exon 11 and sociation rate for IR-A, than for IR-B [16].
    [Show full text]
  • The VE-Cadherin/Amotl2 Mechanosensory Pathway Suppresses Aortic InAmmation and the Formation of Abdominal Aortic Aneurysms
    The VE-cadherin/AmotL2 mechanosensory pathway suppresses aortic inammation and the formation of abdominal aortic aneurysms Yuanyuan Zhang Karolinska Institute Evelyn Hutterer Karolinska Institute Sara Hultin Karolinska Institute Otto Bergman Karolinska Institute Maria Forteza Karolinska Institute Zorana Andonovic Karolinska Institute Daniel Ketelhuth Karolinska University Hospital, Stockholm, Sweden Joy Roy Karolinska Institute Per Eriksson Karolinska Institute Lars Holmgren ( [email protected] ) Karolinska Institute Article Keywords: arterial endothelial cells (ECs), vascular disease, abdominal aortic aneurysms Posted Date: June 15th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-600069/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License The VE-cadherin/AmotL2 mechanosensory pathway suppresses aortic inflammation and the formation of abdominal aortic aneurysms Yuanyuan Zhang1, Evelyn Hutterer1, Sara Hultin1, Otto Bergman2, Maria J. Forteza2, Zorana Andonovic1, Daniel F.J. Ketelhuth2,3, Joy Roy4, Per Eriksson2 and Lars Holmgren1*. 1Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, Sweden. 2Department of Medicine Solna, BioClinicum, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. 3Department of Cardiovascular and Renal Research, Institutet of Molecular Medicine, Univ. of Southern Denmark, Odense, Denmark 4Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm,
    [Show full text]
  • Hepatocyte Growth Factor: a Regulator of Inflammation and Autoimmunity
    Autoimmunity Reviews 14 (2015) 293–303 Contents lists available at ScienceDirect Autoimmunity Reviews journal homepage: www.elsevier.com/locate/autrev Review Hepatocyte growth factor: A regulator of inflammation and autoimmunity Nicolas Molnarfi a,b,1, Mahdia Benkhoucha a,b,1, Hiroshi Funakoshi d, Toshikazu Nakamura e, Patrice H. Lalive a,b,c,⁎ a Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland b Department of Clinical Neurosciences, Division of Neurology, Unit of Neuroimmunology and Multiple Sclerosis, University Hospital of Geneva, Geneva, Switzerland c Department of Genetics and Laboratory Medicine, Laboratory Medicine Service, University Hospital of Geneva, Geneva, Switzerland d Center for Advanced Research and Education, Asahikawa Medical University, Asahikawa, Japan e Neurogen Inc., Nakahozumi, Ibaraki, Osaka, Japan article info abstract Article history: Hepatocyte growth factor (HGF) is a pleiotropic cytokine that has been extensively studied over several decades, Received 20 November 2014 but was only recently recognized as a key player in mediating protection of many types of inflammatory and au- Accepted 25 November 2014 toimmune diseases. HGF was reported to prevent and attenuate disease progression by influencing multiple Available online 1 December 2014 pathophysiological processes involved in inflammatory and immune response, including cell migration, matura- tion, cytokine production, antigen presentation, and T cell effector function. In this review, we discuss the actions Keywords: fl HGF and mechanisms of HGF in in ammation and immunity and the therapeutic potential of this factor for the treat- fl c-Met ment of in ammatory and autoimmune diseases. Inflammation © 2014 Elsevier B.V. All rights reserved. Autoimmunity Autoimmune regulator Therapy Contents 1.
    [Show full text]
  • Regulation of Hematopoietic Stem Cells by the Steel Factor/KIT
    Molecular Pathways Regulation of Hematopoietic Stem Cells by the Steel Factor/KIT Signaling Pathway David Kent, Michael Copley, Claudia Benz, Brad Dykstra, Michelle Bowie, and Connie Eaves Abstract Understanding the intrinsic pathways that regulate hematopoietic stem cell (HSC) proliferation and self-renewal responses to external signals offers a rational approach to developing improved strategies for HSC expansion for therapeutic applications. Such studies are also likely to reveal new targets for the treatment of human myeloid malignancies because perturbations of the biological processes that control normal HSC self-renewal divisions are believed to drive the propagation of many of these diseases. Here, we review recent findings that point to the impor- tance of using stringent functional criteria to define HSCs as cells with longterm repopulating activity and evidence that activation of the KITreceptor and many downstream effectors serve as major regulators of changing HSC proliferative and self-renewal behavior during development. Background the discovery of a rare subset of cells in mice that generate multilineage clones in the spleen of myeloablated recipients Hematopoietic stem cells (HSC) constitute a rare, self- and that are sustained throughout life (10). The finding that sustaining population that appears early in the development these ‘‘colony-forming units spleen’’ are present in all hemato- of the embryo and is then responsible for mature blood cell poietic tissues and exhibit some self-renewal activity when production throughout life. HSC numbers can be regulated serially transplanted led to their use as a tool for establishing extrinsically by three mechanisms: (a) altered exposure to many basic principles expected of an HSC population.
    [Show full text]
  • NKTR-214 2017SITC Poster-P77
    The Novel IL-2 Cytokine Immune Agonist NKTR-214 Harnesses the Adaptive and Innate Immune System for the Treatment of Solid Cancers Salah Eddine Bentebibel1, Chantale Bernatchez1, Cara Haymaker1, Michael Hurwitz3, Patrick Hwu1, Mario Sznol3, Nizar Tannir1, Anthony Conley1, Harriet Kluger3, Sandra Aung2, Michael Imperiale2, Mary Tagliaferri2, Christie Fanton2, Ernesto Iacucci2, Jonathan Zalevsky2, Ute Hoch2, Adi Diab1 1The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America, 2Nektar Therapeutics, San Francisco, CA, United States of America, 3Yale School of Medicine, New Haven, CT, United States of America BACKGROUND RESULTS NKTR-214 Figure 1. NKTR-214 Mechanism of Action Figure 5. NKTR-214 induces activating markers and co-inhibitory Figure 10. Increase in T cell clonality in tumors after treatment • NKTR-214 is a CD122-biased cytokine agonist + NKTR-214 2-PEG 1-PEG receptors in proliferating CD4 T cells in peripheral blood with NKTR-214 conjugated with multiple releasable chains of (6-PEG) Active Cytokine Active Cytokine PD-1 CTLA-4 OX40 ICOS Irreversible Irreversible 15 40 20 80 5 polyethylene glycol (PEG) designed to provide Release Release • An increase in overall T cell n=11 n=15 n=9 n=15 4 (%CD4) sustained signaling through the heterodimeric + 30 60 3 (%CD4) 15 (%CD4) + (%CD4) + clonality observed in 8/12 + 10 + 2 IL-2 receptor pathway (IL-2R) to preferentially 20 1 PD-1 10 40 patients after NKTR-214 OX40 ICOS + + 10 + CTLA-4 LEGEND: + + 0 activate and expand effector CD8 T and NK 5 α Ki-67 treatment 1 NKTR-214 – Inactive 5 20 -1 Melanoma Ki67 Ki-67 5 Ki-67 + Ki-67 cells over Tregs (Figure 1).
    [Show full text]
  • BD Pharmingen™ Purified Mouse Anti-CD247 (Py142)
    BD Pharmingen™ Technical Data Sheet Purified Mouse anti-CD247 (pY142) Product Information Material Number: 558402 Alternate Name: CD3ζ Size: 0.1 mg Concentration: 0.5 mg/ml Clone: K25-407.69 Immunogen: Phosphorylated Human CD3ζ Peptide Isotype: Mouse IgG2a, κ Reactivity: QC Testing: Human Target MW: 21 kDa Storage Buffer: Aqueous buffered solution containing ≤0.09% sodium azide. Description The T cell receptor (TCR), expressed by thymocytes and T lymphocytes, is a multi-component cell-surface complex responsible for recognizing antigen in the context of MHC molecules. The antigen-specific binding component of the TCR, Ti, is a heterodimer of the variable Ig-like subunits a and b or g and d. Ti is non-covalently associated with an invariant set of molecules referred to as the CD3 polypeptides, g, d, e, and ζ. The CD3 z polypeptide (CD3z) was named CD247 at the 7th Human Leukocyte Differentiation Antigens Workshop. CD3 appears early in thymocyte differentiation and remains expressed on all mature T lymphocytes. After antigen recognition by the TCR, CD3z is the primary intracellular signal transducing subunit. It contains three ITAMs (Immunoreceptor Tyrosine-based Activation Motifs), each of which contains a pair of tyrosine residues that are phosphorylated by Lck and Fyn and are required for signal propagation. The molecular weight of CD3z is 16 kDa, and it is also observed as 32-kDa homodimers or as heterodimers with the g chain of Fc receptors. Upon phosphorylation, the CD3z monomer undergoes an apparent shift in electrophoretic mobility up to 21 kDa. The K25-407.69 monoclonal antibody recognizes the phosphorylated tyrosine 142 (pY142) in the third ITAM domain of human CD3z (CD247).
    [Show full text]